rs72704544 — GPM6A GPM6A Neuronal Membrane Glycoprotein

GPM6A: The Neuroplasticity Protein That Stress Silences

Your brain's resilience to chronic stress depends partly on its ability to maintain and remodel the microscopic structures through which neurons communicate. GPM6A¹¹ GPM6A
Glycoprotein M6a — a tetraspan proteolipid protein in the neuronal membrane, related to the myelin proteolipid protein (PLP) family encodes a protein that does exactly this: it scaffolds the formation of dendritic spines and filopodia — the tiny protrusions on neurons where synapses form. When GPM6A expression falls, synaptic architecture degrades. When stress silences the gene, the brain physically loses some of its wiring. The rs72704544 variant in the GPM6A gene was identified in a landmark 2024 anxiety GWAS, linking genetic variation at this locus to anxiety disorder risk across five continental ancestry groups.

The Mechanism

GPM6A protein localizes to membrane protrusions on hippocampal neurons, where it drives filopodium formation²² filopodium formation
Filopodia are thin actin-rich protrusions that develop into mature dendritic spines — the structural basis of long-term potentiation and memory encoding. In cell culture, overexpressing GPM6A dramatically increases filopodial density; silencing it with siRNA reduces filopodial structures and synaptophysin clusters — markers of functional synapses — at highly significant levels (p<0.0001). This makes GPM6A a structural determinant of synaptic connectivity in the hippocampus, the brain region most critical for emotional regulation and stress responses.

Under chronic stress, the gene is specifically downregulated in the dentate gyrus and CA3 region³³ dentate gyrus and CA3 region
The dentate gyrus is one of the few brain regions that generates new neurons in adults (adult neurogenesis); CA3 is the primary output of the hippocampus involved in stress-memory encoding of the hippocampus — the circuit most vulnerable to stress-induced atrophy. This downregulation occurs alongside suppression of BDNF, the brain's primary neurotrophic growth factor. miR-124-3p⁴⁴ miR-124-3p
A microRNA highly expressed in neurons that promotes neuronal differentiation by suppressing non-neuronal gene programs, a key regulator of GPM6A expression, is also reduced by chronic stress, providing a molecular mechanism for the gene's silencing. BDNF treatment in vitro rescues miR-124-3p and GPM6A expression together, suggesting the BDNF-miR-124-GPM6A axis is a recoverable pathway.

Rs72704544 is an intronic variant — it does not change the GPM6A protein sequence. Its likely mechanism is regulatory: intronic variants near regulatory elements can alter splicing efficiency, transcription factor binding, or enhancer activity, modifying how much GPM6A protein the hippocampus produces, particularly under stress conditions. The G allele at this locus was identified as the risk-increasing variant for anxiety disorders.

The Evidence

The primary human genetic evidence comes from a 2024 multi-ancestry GWAS⁵⁵ 2024 multi-ancestry GWAS
Friligkou E et al. "Gene discovery and biological insights into anxiety disorders from a large-scale multi-ancestry genome-wide association study." Nature Genetics, 2024. by Friligkou et al. in Nature Genetics. The study enrolled over 1.2 million participants including 97,383 anxiety disorder cases across five continental ancestry groups. Fifty-one genome-wide significant loci were identified, 39 of which were novel; heritability enrichment was concentrated in genes expressed in the limbic system, cerebral cortex, and hippocampus. GPM6A was among the 115 genes associated with anxiety through brain-specific transcriptome analysis. The study also documented genetic overlap with depression, schizophrenia, and bipolar disorder — consistent with GPM6A's broad role in synaptic plasticity across mood disorders.

The human postmortem literature provides direct biological validation. A postmortem hippocampal study of 18 depressed suicides⁶⁶ postmortem hippocampal study of 18 depressed suicides
Fuchsova B et al. "Altered expression of neuroplasticity-related genes in the brain of depressed suicides." Neuroscience, 2015. found statistically significant downregulation of GPM6A in depressed individuals (F=14.55, p=0.0002), alongside CAMK2A and CORO1A — all neuroplasticity-related genes. Normal coexpression patterns among these genes were disrupted in depressed brains, suggesting a systems-level failure of hippocampal plasticity maintenance.

In the stress model literature, three weeks of daily restraint stress in rats⁷⁷ three weeks of daily restraint stress in rats
Cooper B et al. "Expression of the axonal membrane glycoprotein M6a is regulated by chronic stress." PLoS One, 2009. consistently downregulates M6a mRNA in dentate gyrus and CA3 neurons. This finding has been independently replicated and extended: Alfonso et al. 2006⁸⁸ Alfonso et al. 2006
Alfonso J et al. "Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments." Biological Psychiatry, 2006. showed stress-induced M6a suppression is conserved across species and stressors, and critically, reversed by the antidepressant tianeptine.

Practical Actions

There is no established pharmacogenomic consequence for rs72704544 — it is a risk modifier, not a drug-response determinant. The practical implications concern neuroplasticity maintenance: factors that support BDNF-driven hippocampal remodeling directly address the pathway this variant affects. Among lifestyle exposures with solid evidence for increasing BDNF and GPM6A expression are aerobic exercise (especially sustained moderate-intensity training), omega-3 fatty acids (EPA/DHA), and avoiding sustained elevation of glucocorticoids. Chronic psychological stress specifically suppresses the BDNF–miR-124–GPM6A axis; interventions that reduce HPA-axis hyperactivation are mechanistically relevant.

For individuals with GG genotype (rare, ~3.4% globally) carrying two risk alleles, both clinician awareness of elevated baseline anxiety risk and proactive monitoring of mood symptoms may be warranted.

Interactions

GPM6A is closely related to GPM6B, its paralogous protein; GPM6B directly interacts with the N-terminal domain of the serotonin transporter (SERT, SLC6A4), decreasing SERT cell-surface expression and serotonin reuptake. While GPM6A's direct interaction with SERT is less established than GPM6B's, both proteins share structural homology and hippocampal expression, suggesting a potential functional convergence in serotonergic modulation.

Rs72704544 is worth considering alongside FKBP5 rs1360780 — the classic stress-axis variant. Both variants affect hippocampal gene expression under chronic stress and both have been associated with anxiety and stress-related phenotypes. The FKBP5 variant impairs glucocorticoid receptor feedback; GPM6A affects the downstream structural consequences of glucocorticoid-mediated neuroplasticity suppression. A compound interaction analysis across these two loci would be biologically motivated.